David Dornan
Chief Tech/Sci/R&D Officer chez ELEVATION ONCOLOGY, INC.
Fortune : - $ au 31/03/2024
Profil
David Dornan is currently the Chief Scientific Officer at Elevation Oncology, Inc. Prior to this, he was the Senior Vice President of Research & Manufacturing at Bolt Biotherapeutics, Inc. from 2019 to 2022.
From 2012 to 2017, he worked at Gilead Sciences, Inc. as the Director & Head of Oncology Research.
Dr. Dornan holds a doctorate degree from the University of Dundee and an undergraduate degree from the University of Strathclyde.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ELEVATION ONCOLOGY, INC.
-.--% | 15/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de David Dornan
| Sociétés | Poste | Début |
|---|---|---|
| ELEVATION ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 14/03/2022 |
Anciens postes connus de David Dornan
| Sociétés | Poste | Fin |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 11/03/2022 |
| GILEAD SCIENCES, INC. | Director/Board Member | 01/11/2017 |
Formation de David Dornan
| University Of Dundee | Doctorate Degree |
| University of Strathclyde | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| BOLT BIOTHERAPEUTICS, INC. | Health Technology |
| ELEVATION ONCOLOGY, INC. | Health Technology |
